CASI Pharmaceuticals, Inc (DE) Quarterly Return On Assets in % from Q1 2012 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Return On Assets for the quarter ending December 31, 2022 was -34.7 %, a 34.3% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Return On Assets for 2022 was -34.7 %, a 34.3% decline from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Return On Assets for 2021 was -25.9 %, a 39.4% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Return On Assets for 2020 was -42.6 %, a 6.47% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -34.7 -8.87 -34.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -21.1 +11.5 +35.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -24.6 +12.9 +34.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -22.9 +20 +46.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -25.9 +16.8 +39.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.5 +11 +25.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -37.5 +1.76 +4.48% Apr 1, 2021 Jun 30, 2021
Q1 2021 -42.8 +0.4 +0.93% Jan 1, 2021 Mar 31, 2021
Q4 2020 -42.6 -2.59 -6.47% Oct 1, 2020 Dec 31, 2020
Q3 2020 -43.5 -7.16 -19.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -39.3 -4.66 -13.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -43.2 -14.9 -52.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -40 -12.1 -43.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -36.4 -7.7 -26.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -34.6 -6.16 -21.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -28.3 +2.71 +8.73% Jan 1, 2019 Mar 31, 2019
Q4 2018 -28 +8.48 +23.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -28.7 +4.65 +13.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -28.4 +4.56 +13.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -31.1 +7.3 +19% Jan 1, 2018 Mar 31, 2018
Q4 2017 -36.5 +7.52 +17.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -33.3 +19.6 +37.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -33 +39.3 +54.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -38.4 +41.6 +52% Jan 1, 2017 Mar 31, 2017
Q4 2016 -44 +47 +51.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 -53 +23.5 +30.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -72.3 +182 +71.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -79.9 +144 +64.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -91 +111 +55% Oct 1, 2015 Dec 31, 2015
Q3 2015 -76.4 +109 +58.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -255 -216 -555% Apr 1, 2015 Jun 30, 2015
Q1 2015 -224 -186 -492% Jan 1, 2015 Mar 31, 2015
Q4 2014 -202 -168 -497% Oct 1, 2014 Dec 31, 2014
Q3 2014 -185 -154 -492% Jul 1, 2014 Sep 30, 2014
Q2 2014 -38.9 -5.33 -15.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -37.9 +74.5 +66.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -33.9 +111 +76.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -31.3 +121 +79.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -33.5 +158 +82.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 -112 -28.9 -34.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -144 Oct 1, 2012 Dec 31, 2012
Q3 2012 -153 Jul 1, 2012 Sep 30, 2012
Q2 2012 -192 Apr 1, 2012 Jun 30, 2012
Q1 2012 -83.5 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.